Furthermore, the combination of our in vitro and patient data suggested a multifaceted relationship between cancer and immune cells in the tumor microenvironment that hinge on interactions among MUFA, HMGB1 and PD-L1, potentially influencing the immunological sensitivity of tumors to current and future immunotherapies (Figure 8G). Here, HMGB1 is linked to cancer.